Related Experiment Video
Updated: Jul 13, 2025

Employing the Forced Oscillation Technique for the Assessment of Respiratory Mechanics in Adults
Published on: February 9, 2022
Childhood TB sequel: evaluating respiratory function after treatment for pulmonary tuberculosis in a prospective
Esin Nkereuwem1,2, Schadrac Agbla3,4, Muhammed Lamin Jatta5
1Vaccines and Immunity Theme, MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Atlantic Boulevard, Fajara, The Gambia. esin.nkereuwem@lshtm.ac.uk.
Insights
Tuberculosis (TB) can cause lasting lung damage in children, even after successful treatment. The Childhood TB Sequel study investigates these post-TB lung disease (PTLD) consequences and risk factors in Gambian children.
Area of Science:
- Pediatric pulmonology
- Infectious diseases
- Global health
Background:
- Tuberculosis (TB) affects 1.2 million children globally each year, with 85% achieving treatment success.
- However, successful TB treatment often results in long-term lung damage, known as post-TB lung disease (PTLD).
- Limited data exists on the burden and progression of PTLD in pediatric populations.
Purpose of the Study:
- To describe the respiratory consequences of pulmonary TB in Gambian children.
- To track the evolution of these lung sequelae over time.
- To identify epidemiological risk factors associated with PTLD in children.
Main Methods:
- Recruitment of up to 80 children (aged ≤19 years) recently treated for pulmonary TB.
- Data collection includes clinical assessments, chest X-rays, and comprehensive lung function tests.
- Assessments are conducted at treatment completion, and at 6 and 12 months post-treatment.
Main Results:
- This section is to be filled once the study results are available.
Conclusions:
- The Childhood TB Sequel study aims to fill critical knowledge gaps regarding PTLD in children.
- Findings will inform the development of post-TB evaluation and long-term follow-up strategies.
- This research is crucial for improving the long-term health outcomes of childhood TB survivors.
Background:
1.2 million children under 15 years are estimated to have developed tuberculosis (TB) in 2021. 85% of paediatric patients achieve successful treatment outcomes if treated for the first episode of TB. However, despite so-called successful treatment, TB leaves many survivors with permanently destroyed or damaged lungs. Data from prospective paediatric cohorts to establish the burden and evolution of post-TB lung disease (PTLD) are still absent. The Childhood TB Sequel study aims to describe respiratory consequences associated with pulmonary TB in Gambian children, describe the evolution of these sequelae, and determine associated epidemiological risk factors.
Methods:
We aim to recruit up to 80 subjects aged 19 years and below who have recently completed treatment for pulmonary TB. Recruitment started in April 2022 and is expected to continue until June 2024. Clinical assessment, chest X-ray, and comprehensive lung function assessment are carried out at treatment completion and again six and 12 months later.
Discussion:
The Childhood TB Sequel study will address existing research gaps to enhance our knowledge and understanding of the burden of PTLD in Gambian children. The study will also contribute to formulating a plan for post-TB evaluation and long-term follow-up strategies.
Trial Registration:
ClinicalTrials.gov: NCT05325125, April 13, 2022.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...

